These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29593747)

  • 1. Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8
    Soema PC; Rosendahl Huber SK; Willems GJ; Jacobi R; Hendriks M; Soethout E; Jiskoot W; de Jonge J; van Beek J; Kersten GFA; Amorij JP
    Front Immunol; 2018; 9():525. PubMed ID: 29593747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.
    Budimir N; de Haan A; Meijerhof T; Waijer S; Boon L; Gostick E; Price DA; Wilschut J; Huckriede A
    PLoS One; 2013; 8(5):e63163. PubMed ID: 23658804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
    Bodewes R; Kreijtz JH; Hillaire ML; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Gen Virol; 2010 Jul; 91(Pt 7):1743-53. PubMed ID: 20335492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved peptides enhance immune efficiency of inactive vaccines against emerging avian influenza viruses in chicken.
    Xiao J; Zhang L; Wang Z; Xiang W; Lu P; Zhao Y; Han M; Ma A; Qi P; Wang M; Gao GF; Liu WJ
    Sci China Life Sci; 2017 Dec; 60(12):1340-1347. PubMed ID: 29230639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.
    Di Mario G; Garulli B; Sciaraffia E; Facchini M; Donatelli I; Castrucci MR
    Virol J; 2016 Mar; 13():56. PubMed ID: 27036323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine.
    Geeraedts F; ter Veer W; Wilschut J; Huckriede A; de Haan A
    Vaccine; 2012 Oct; 30(45):6501-7. PubMed ID: 22841974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.
    Suneetha PV; Schlaphoff V; Wang C; Stegmann KA; Fytili P; Sarin SK; Manns MP; Cornberg M; Wedemeyer H
    J Immunol Methods; 2009 Mar; 342(1-2):33-48. PubMed ID: 19135447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.
    Rosendahl Huber SK; Luimstra JJ; van Beek J; Hoppes R; Jacobi RH; Hendriks M; Kapteijn K; Ouwerkerk C; Rodenko B; Ovaa H; de Jonge J
    PLoS One; 2016; 11(6):e0156462. PubMed ID: 27333291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
    van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
    Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice.
    Hinkula J; Nyström S; Devito C; Bråve A; Applequist SE
    Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31315253
    [No Abstract]   [Full Text] [Related]  

  • 14. Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine.
    Soema PC; Rosendahl Huber SK; Willems GJ; Jiskoot W; Kersten GF; Amorij JP
    Pharm Res; 2015 Apr; 32(4):1505-15. PubMed ID: 25344321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.
    Budimir N; Meijerhof T; Wilschut J; Huckriede A; de Haan A
    Vaccine; 2010 Dec; 28(52):8280-7. PubMed ID: 20965298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.
    Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC
    Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved peptides containing overlapping CD4+ and CD8+ T-cell epitopes in the H1N1 influenza virus: an immunoinformatics approach.
    Lohia N; Baranwal M
    Viral Immunol; 2014 Jun; 27(5):225-34. PubMed ID: 24821387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
    J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Fomsgaard A; Karlsson I; Gram G; Schou C; Tang S; Bang P; Kromann I; Andersen P; Andreasen LV
    Vaccine; 2011 Sep; 29(40):7067-74. PubMed ID: 21767590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.